The global lung cancer therapeutics industry demand is anticipated to increase strongly from 2022 to 2032, with a total CAGR of 13.4%. The estimated value of the global market in 2026 is US$ 48,725.9 million. The market for lung cancer medications is predicted to expand in tandem with rising regulatory approvals and European acceptance of …
Category Archives: Healthcare Trends
Global Critical Care Drugs Industry is projected to grow at a CAGR of 5% to 6% through 2032, as per FMI’s predictions
As per recent market analysis, the global critical care drugs industry size is on an upward trajectory, foreseeing a steady Compound Annual Growth Rate (CAGR) ranging from 5% to 6% from 2022 to 2032. Projections indicate substantial revenue generation by the conclusion of this forecast period. The escalating prevalence of diverse chronic ailments worldwide has …
Global Medical Bed Industry is projected to exceed US$ 5,469.0 Million by 2033, according to FMI analysts
The global medical bed industry demand is projected to surpass US$ 3,611.9 million in 2023 and is likely to attain a valuation of US$ 5,469.0 million by 2033. The medical bed market share is expected to rise at a CAGR of 4.2% from 2023 to 2033. Environmental sustainability is becoming increasingly crucial in the healthcare …
Global Ischemic Stroke Aspiration Systems Industry is forecasted to surpass US$ 1,672.8 Million by 2033, according to FMI’s estimation
According to a study by FMI, the global ischemic stroke aspiration systems industry growth is expected to reach around US$ 648.7 million in 2023. The overall market is anticipated to continue expanding at an outstanding CAGR of 9.9% over the forecast years from 2023 to 2033. A substantial market expansion has been made possible by …
Global Digital Patient Monitoring Systems Industry is projected to surpass US$ 470 Billion by 2032, according to FMI
The global digital patient monitoring systems industry demand is anticipated to be worth US$ 96.4 billion in 2022 and US$ 470 billion by 2032, growing at a CAGR of 17.2% during the forecast period of 2022–2032. The digital patient monitoring systems market has expanded significantly in recent years as a result of technological improvements, an …
Global Foot and Ankle Devices Industry is projected to achieve a 5.9% CAGR, potentially reaching US$ 7.8 Billion by 2032 | FMI
Recent projections indicate a robust growth trajectory for the global foot and ankle devices industry, and FMI is well-positioned to capitalize on this expanding market. The industry is expected to experience a remarkable Compound Annual Growth Rate (CAGR) of 5.9% between 2022 and 2032, propelling the market value from US$ 4.4 billion in 2022 to …
Global Female Stress Urinary Incontinence Treatment Devices Industry Set to Soar at a Remarkable 6.2% CAGR, Projecting US$1.07 Billion by 2029 | FMI
The Global Female Stress Urinary Incontinence Treatment Devices Industry is poised for unprecedented growth, currently valued at an impressive US$ 702.4 million. Recent forecasts indicate an upward trajectory, with a robust compound annual growth rate (CAGR) of 6.2% anticipated from 2022 to 2029. This momentum is expected to drive the market to a staggering US$ …
Global Surgical Booms Industry on Track to Reach US$380.2 Million by 2029, Propelled by a Consistent 4.7% Compound Annual Growth Rate | FMI
The latest research by Future Market Insights (FMI) unveils a promising future for the Global Surgical Booms Industry, also known as Equipment Management Systems (EMS). Surgical booms, crucial components in operating rooms (ORs), play a pivotal role in managing electrical wiring from various equipment and optimizing the working space. Surgical booms, suspended from the OR …
Global Venous Thromboembolism Treatment Industry on Track for a Remarkable 3.7% CAGR Surge by 2029 | Reveals Future Market Insights Inc.
The Global Venous Thromboembolism Treatment Industry is poised for substantial and steady growth in the coming years, according to a comprehensive study conducted by Future Market Insights (FMI). The market is projected to witness an impressive Compound Annual Growth Rate (CAGR) of approximately 3.7% between 2022 and 2029. The FMI study highlights that deep venous …
Global Mucopolysaccharidosis (MPS) Treatment Industry Sees Impressive Growth, Projecting a 5.9% CAGR, Eyeing US$ 3.37 Billion by 2029 | Reports FMI
In 2022, the Global Mucopolysaccharidosis (MPS) Treatment Industry is poised for substantial growth, with an estimated worth of US$2.38 billion. Projections indicate a robust Compound Annual Growth Rate (CAGR) of 5.9% from 2022 to 2029, culminating in a market valuation of US$ 3.37 billion by the end of the forecast period. This surge is attributed …